Mentor Corp. maker of medical supplies for the "aesthetics" end of the market is officially a PIC candidate after years of good growth and now a poor 12 month forecast and low Timeliness ranking.
Recently MNT sold off the entire urological division which has significantly changed the nature of the company. I'd suggested that you read up on this stock and the recent activities in Value Line before considering buying any. The future of the remaining aesthetics business looks good and could be pretty "perky" if their new silicone implant is approved.
I think that as usual, the first year could be a bit tricky for non-AIM investors but those who choose the AIM volatility capture method might be able to build a solid position. Value Line thinks the stock could do well in the 3-5 year time frame. It's ranked as follows:
None of these indicate that it will be a highly active AIM trader, but if one is seeking long term price appreciation and a bit of a dividend, too, it could do well in total return.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.